95 related articles for article (PubMed ID: 16583211)
21. Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.
Li B; Wang Y; Chen J; Wu H; Chen W
Clin Exp Immunol; 2005 May; 140(2):310-9. PubMed ID: 15807856
[TBL] [Abstract][Full Text] [Related]
22. The nature of peptides presented by an HLA class I low expression allele.
Hinrichs J; Föll D; Bade-Döding C; Huyton T; Blasczyk R; Eiz-Vesper B
Haematologica; 2010 Aug; 95(8):1373-80. PubMed ID: 20220067
[TBL] [Abstract][Full Text] [Related]
23. A novel HLA-A31 allele, A*31:22, was identified by sequence-based typing.
Zhang WW; Li XF; Zhang X; Li JP; Li ZQ
Tissue Antigens; 2012 Oct; 80(4):380-1. PubMed ID: 22861819
[TBL] [Abstract][Full Text] [Related]
24. Two epitopes and one agretope map to a single HLA-A2 peptide recognized by H-2-restricted T cells.
Martinon F; Cornille F; Gomard E; Fournie-Zaluski MC; Abastado JP; Roques BP; Levy JP
J Immunol; 1989 May; 142(10):3489-94. PubMed ID: 2469716
[TBL] [Abstract][Full Text] [Related]
25. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel allele HLA-A*1113 in a Japanese donor.
Takahashi D; Miyazaki T; Araseki M; Sekimoto T; Sato S; Kato T; Ikeda H
Tissue Antigens; 2004 Jul; 64(1):81-3. PubMed ID: 15191528
[TBL] [Abstract][Full Text] [Related]
27. The amino acid variation of HLA-A*02:182 in a highly conserved region is predicted to be functionally similar to HLA-A*02:01:01:01 allele.
Wurm M; Tischer S; Immenschuh S; Bade-Doeding C; Blasczyk R; Eiz-Vesper B
Tissue Antigens; 2011 Feb; 77(2):149-50. PubMed ID: 20946190
[TBL] [Abstract][Full Text] [Related]
28. Promiscuous Recognition of a Trypanosoma cruzi CD8+ T Cell Epitope among HLA-A2, HLA-A24 and HLA-A1 Supertypes in Chagasic Patients.
Lasso P; Beltrán L; Guzmán F; Rosas F; Thomas MC; López MC; González JM; Cuéllar A; Puerta CJ
PLoS One; 2016; 11(3):e0150996. PubMed ID: 26974162
[TBL] [Abstract][Full Text] [Related]
29. A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.
Karkada M; Weir GM; Quinton T; Sammatur L; MacDonald LD; Grant A; Liwski R; Juskevicius R; Sinnathamby G; Philip R; Mansour M
J Immunother; 2010 Apr; 33(3):250-61. PubMed ID: 20445345
[TBL] [Abstract][Full Text] [Related]
30. Identification of the new HLA-A*31:48 allele in an Italian patient.
Testi M; Battarra M; Troiano M; Condello R; Andreani M
Tissue Antigens; 2011 Oct; 78(4):286-7. PubMed ID: 21623737
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel HLA-A allele HLA-A*02:227N.
Wang L; Zhang ZX; Shan XY; Liu N; Ni L
Tissue Antigens; 2013 Jan; 81(1):46-7. PubMed ID: 22994261
[TBL] [Abstract][Full Text] [Related]
32. Identification of HLA-A2- and A24-restricted T-cell epitopes derived from SOX6 expressed in glioma stem cells for immunotherapy.
Ueda R; Ohkusu-Tsukada K; Fusaki N; Soeda A; Kawase T; Kawakami Y; Toda M
Int J Cancer; 2010 Feb; 126(4):919-29. PubMed ID: 19728337
[TBL] [Abstract][Full Text] [Related]
33. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
[TBL] [Abstract][Full Text] [Related]
34. A study of functionally active amino acids involved in the interaction of HLA-A2 or HLA-A3 molecules with cytolytic T lymphocytes.
Healy F; Sire J; Gomard E; Yssel H; Jordan B; Levy JP
J Immunol; 1988 Oct; 141(7):2487-96. PubMed ID: 2459213
[TBL] [Abstract][Full Text] [Related]
35. Two novel HLA-A alleles: HLA-A*31:01:09 and HLA-A*33:30.
Ji Y; Sun Y; Liu Y; Xie J; Du K
Tissue Antigens; 2011 Sep; 78(3):218-9. PubMed ID: 21623730
[TBL] [Abstract][Full Text] [Related]
36. Structural aspect of novel HLA-A*02 allele, A*0286, identified by sequence-based typing.
Heo YS; Hwang SH; Kwon OJ; Hur SS; Oh HB
Tissue Antigens; 2006 Jan; 67(1):84-5. PubMed ID: 16451209
[No Abstract] [Full Text] [Related]
37. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
Hoof I; Pérez CL; Buggert M; Gustafsson RK; Nielsen M; Lund O; Karlsson AC
J Immunol; 2010 May; 184(9):5383-91. PubMed ID: 20363973
[TBL] [Abstract][Full Text] [Related]
38. Intergenic recombination with HLA-C leads to a novel HLA-A*19 allele, HLA-A*2910, that is characterized by a functionally inactive amino acid exchange in the loop connecting the alpha and alpha domains.
Mosebach M; Brixner V; Bader P; Klingebiel TH; Seifried E; Seidl C
Tissue Antigens; 2006 Jan; 67(1):75-8. PubMed ID: 16451207
[TBL] [Abstract][Full Text] [Related]
39. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
[TBL] [Abstract][Full Text] [Related]
40. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.
Rice J; Dunn S; Piper K; Buchan SL; Moss PA; Stevenson FK
Cancer Res; 2006 May; 66(10):5436-42. PubMed ID: 16707472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
